202 related articles for article (PubMed ID: 17699321)
21. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
22. Analyzing fatal cases of Chinese patients with primary antineutrophil cytoplasmic antibodies-associated renal vasculitis: a 10-year retrospective study.
Chen YX; Yu HJ; Zhang W; Ren H; Chen XN; Shen PY; Xu YW; Li X; Pan XX; Ni LY; Wang WM; Chen N
Kidney Blood Press Res; 2008; 31(5):343-9. PubMed ID: 18946225
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
24. Primary renal vasculitis in Norfolk--increasing incidence or increasing recognition?
Lane SE; Scott DG; Heaton A; Watts RA
Nephrol Dial Transplant; 2000 Jan; 15(1):23-7. PubMed ID: 10607763
[TBL] [Abstract][Full Text] [Related]
25. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
[TBL] [Abstract][Full Text] [Related]
26. Primary systemic vasculitis: clinical features and mortality.
Lane SE; Watts RA; Shepstone L; Scott DG
QJM; 2005 Feb; 98(2):97-111. PubMed ID: 15655098
[TBL] [Abstract][Full Text] [Related]
27. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Papo M; Sinico RA; Teixeira V; Venhoff N; Urban ML; Iudici M; Mahrhold J; Locatelli F; Cassone G; Schiavon F; Seeliger B; Neumann T; Kroegel C; Groh M; Marvisi C; Samson M; Barba T; Jayne D; Troilo A; Thiel J; Hellmich B; Monti S; Montecucco C; Salvarani C; Kahn JE; Bonnotte B; Durel CA; Puéchal X; Mouthon L; Guillevin L; Emmi G; Vaglio A; Terrier B;
Rheumatology (Oxford); 2021 Sep; 60(9):4355-4360. PubMed ID: 33347592
[TBL] [Abstract][Full Text] [Related]
28. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
[TBL] [Abstract][Full Text] [Related]
29. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
30. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
Zhang X; Dong Y; Zeng X; Li Y; Tang F
Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
[TBL] [Abstract][Full Text] [Related]
31. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
32. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis.
Mareen P; Van De Walle S; Bernaert P; Vanhouteghem H; Dierick J
Acta Clin Belg; 2003; 58(3):193-200. PubMed ID: 12945480
[TBL] [Abstract][Full Text] [Related]
33. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
34. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
35. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
37. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
Reynolds WF; Stegeman CA; Tervaert JW
Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
[TBL] [Abstract][Full Text] [Related]
38. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides.
Borgmann S; Haubitz M
Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S79-86. PubMed ID: 15675141
[TBL] [Abstract][Full Text] [Related]
39. [Antineutrophil cytoplasmic antibodies].
Sebastiani GD
Reumatismo; 2009; 61(1):69-76. PubMed ID: 19370191
[TBL] [Abstract][Full Text] [Related]
40. ANCA-associated vasculitis in childhood: recent advances.
Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
